Aquestive Therapeutics
AQST
#6501
Rank
HK$5.79 B
Marketcap
HK$47.46
Share price
-7.85%
Change (1 day)
56.95%
Change (1 year)

Operating Margin for Aquestive Therapeutics (AQST)

Operating Margin as of December 2025 (TTM): -119.69%

According to Aquestive Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -119.69%. At the end of 2024 the company had an Operating Margin of -76.70%.

Operating Margin history for Aquestive Therapeutics from 2017 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-76.70%408.83%
2023-15.07%-86.79%
2022-114.11%-17.77%
2021-138.77%14.06%
2020-121.67%-3.38%
2019-125.92%38.34%
2018-91.02%581.09%
2017-13.36%-27.93%
2016-18.54%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Onconova Therapeutics
ONTX
-8,391.15% 6,910.74%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-24.83%-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.